How to Inject PT-141

How Do You Inject PT-141?

PT-141 is administered via subcutaneous self-injection. For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Melanocortin receptor agonist compounds.

This guide covers injection technique, site selection, needle choices, and common mistakes.

How Do You Prepare for a PT-141 Injection?

Step 1: Wash your hands thoroughly.

Step 2: Clean the top of the PT-141 vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our PT-141 reconstitution guide.

Step 3: Draw your dose (1.75 mg per dose (FDA-approved)) into an insulin syringe. Use our calculator for exact units.

Step 4: Clean the injection site with an alcohol swab and let it dry.

What Is the Correct Injection Technique?

Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.

Intramuscular (less common for PT-141): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.

Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).

What Size Needle Should You Use?

For subcutaneous PT-141 injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.

Use a fresh needle for every injection. Never reuse or share needles.

What Are Common Injection Side Effects?

Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.

If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.

Bottom Line on PT-141 Injection

PT-141 is administered via subcutaneous self-injection at 1.75 mg per dose (FDA-approved) on-demand, 45 minutes before anticipated activity; maximum 8 doses per month. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.

Related Reading

• PT-141 Dosage Guide
• PT-141 Benefits
• PT-141 Side Effects
• PT-141 Stacking Guide
• PT-141 Cycle Guide
• PT-141 Research

Frequently Asked Questions